Skip to main content
Caplight Logo









Exo

Exo

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.exo.inc/

Last Round

Series D

Jun 11, 2025

Total Funding Raised

$383.89M

Company Overview

Exo is a medical technology company that develops a handheld ultrasound device and AI-powered diagnostic and workflow software platform designed to enhance medical imaging and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

handheld ultrasoundpoint-of-care ultrasoundPOCUSmedical imaging AIdiagnostic imagingportable ultrasoundultrasound softwareclinical AIbedside diagnosticsultrasound guidancedigital healthmedical devicepocket ultrasound

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exo Comparables

Compare Exo with similar companies based on industry and business-model similarity.

Exo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EchoNous
92%
Clarius Mobile Health
89%
Butterfly Network
86%

Exo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJun 11, 2025
DebtJul 29, 2024
Series CJul 29, 2021
Series B ExtensionAug 20, 2020
Series BAug 5, 2019
Series A
Oct 2, 2017

Key People

Founding team and executive leadership

Yusuf Haque

Co Founder Chief Technical Officer

Founding Team

Alisha Johnson

Group CEO

Executive Team

Sandeep Akkaraju

CEO Founder

Founding Team

Exo Investors

Notable investors and investment history

Exo investors
InvestorRounds
Rising Tide FundSeries B Extension, Series C, Seed, Series B
Boldstart VenturesSeries B Extension, Series C
RA Capital ManagementSeries C
Sony Ventures CorporationSeed, Series B
Magnetar CapitalSeed, Series B, Series B Extension
Longevity Vision FundSeries B Extension, Series B, Series C, Seed
Creative VenturesSeries B Extension, Series C, Seed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    Sponsoring refreshment break at MEDTECH IMPACT SYMPOSIUM.

  • Jun 18, 2025

    New ultrasound AI cleared by FDA for detecting pleural effusion and consolidation/atelectasis.

Exo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exo's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range186
Year Founded2015
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.